BIIB
Biogen Inc
Price:  
200.81 
USD
Volume:  
834,701.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Biogen WACC - Weighted Average Cost of Capital

The WACC of Biogen Inc (BIIB) is 8.2%.

The Cost of Equity of Biogen Inc (BIIB) is 9.15%.
The Cost of Debt of Biogen Inc (BIIB) is 4.40%.

Range Selected
Cost of equity 8.00% - 10.30% 9.15%
Tax rate 13.90% - 16.80% 15.35%
Cost of debt 4.00% - 4.80% 4.40%
WACC 7.2% - 9.1% 8.2%
WACC

Biogen WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.91 0.98
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.00% 10.30%
Tax rate 13.90% 16.80%
Debt/Equity ratio 0.23 0.23
Cost of debt 4.00% 4.80%
After-tax WACC 7.2% 9.1%
Selected WACC 8.2%